Xingang shares: the shareholding ratio of controlling shareholders decreased from 50.16% to 49.13%

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Brazil's Semiconductors Get Boost: Incentives to Draw 30Bn Reais in a Decade

WOU Pioneers AI Education with Complimentary Access to 80 Generative AI Courses

In a strategic move to equip its students with crucial skills for the digital economy, Wawasan Open University (WOU) has announced that it will provide unlimited complimentary access to 80 carefully curated Generative Artificial Intelligence (Gen AI) courses.

Top 10 Market Cap Chinese Medical Device Companies: Champions and Runners-Up

In a recent boom in the Chinese A-share market, the medical device segment has shown a surprising performance, proving its investability and growth potential.

USD 130 Million Series A Financing Fuels Lepu Biotech

Lepu Biotech announced Series A financing of CNY 900 million. Shiyu Capital took the lead in this round. Lepu Biotech has several pipelines for precision treatment and targeted therapy for solid tumors.